Gilles van Luijtelaar Selected Research

Gilles van Luijtelaar Research Topics

Disease

24	Absence Epilepsy (Childhood Absence Epilepsy) 01/2021 - 07/2003
21	Seizures (Absence Seizure) 01/2023 - 06/2004
7	Epilepsy (Aura) 02/2023 - 06/2004
2	Generalized Epilepsy 11/2017 - 11/2016
2	Schizophrenia (Dementia Praecox) 11/2015 - 01/2013
2	Anhedonia 06/2011 - 01/2010
1	Temporal Lobe Epilepsy 01/2019
1	Gliosis 01/2019
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019
1	Spasm (Spasms) 01/2017
1	Reflex Epilepsy (Photosensitive Epilepsy) 11/2016
1	Pain (Aches) 06/2013
1	Depressive Disorder (Melancholia) 06/2011
1	Body Weight (Weight, Body) 01/2011
1	Idiopathic Generalized Epilepsy 07/2007

Drug/Important Bio-Agent (IBA)

4	Ethosuximide (Zarontin)FDA LinkGeneric 01/2019 - 07/2012
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2021 - 07/2011
3	N- cyclobutyl- 6- ((3- fluorophenyl)ethynyl)nicotinamideIBA 11/2020 - 07/2015
3	Glutamic Acid (Glutamate)FDA Link 01/2018 - 07/2011
3	gamma-Aminobutyric Acid (GABA)IBA 07/2015 - 04/2007
3	Progesterone FDA LinkGeneric 12/2014 - 07/2003
3	Hormones (Hormone)IBA 05/2012 - 06/2004
2	Cannabinoid Receptor AgonistsIBA 01/2023 - 01/2020
2	ThrombospondinsIBA 11/2017 - 01/2017
2	LigandsIBA 11/2017 - 01/2017
2	CannabinoidsIBA 01/2017 - 08/2010
2	PlasticsIBA 12/2016 - 08/2010
2	Anticonvulsants (Antiepileptic Drugs)IBA 06/2013 - 06/2011
2	Sucrose (Saccharose)IBA 06/2011 - 01/2010
2	SteroidsIBA 05/2007 - 06/2004
1	Dopamine (Intropin)FDA LinkGeneric 02/2023
1	Vigabatrin FDA Link 01/2020
1	trans- 1,4- Bis(2- chlorobenzaminomethyl)cyclohexane DihydrochlorideIBA 11/2019
1	CholesterolIBA 11/2019
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019
1	SolventsIBA 01/2019
1	LithiumIBA 01/2019
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2019
1	Immunoglobulin E (IgE)IBA 11/2017
1	Calcium Channels (Calcium Channel)IBA 01/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2017
1	Pregabalin (Lyrica)FDA Link 01/2017
1	Cannabinoid Receptor AntagonistsIBA 01/2017
1	RimonabantIBA 01/2017
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2017
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2017
1	Histamine Receptors (Histamine Receptor)IBA 11/2016
1	Aminobutyrates (Aminobutyric Acid)IBA 07/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2015
1	Tiagabine (Gabitril)FDA Link 07/2015
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2014
1	Testosterone (Sustanon)FDA Link 12/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2013
1	palmidrolIBA 06/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2013
1	GlucocorticoidsIBA 05/2012
1	Psychotropic Drugs (Psychoactive Drugs)IBA 06/2011
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2011
1	EndocannabinoidsIBA 01/2011
1	Phosphotransferases (Kinase)IBA 01/2010
1	CreatineIBA 01/2010
1	Pentylenetetrazole (Metrazol)IBA 01/2010
1	Cholinergic Agents (Cholinergics)IBA 10/2009
1	GABA-A Receptors (GABA(A) Receptor)IBA 07/2007
1	Protein Subunits (Protein Subunit)IBA 07/2007
1	Phenytoin (Dilantin)FDA LinkGeneric 08/2006
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2005
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2005
1	Clonidine (ST 155)FDA LinkGeneric 01/2005
1	Lidocaine (Xylocaine)FDA LinkGeneric 06/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2004
1	CorticosteroneIBA 06/2004
1	Kynurenic Acid (Kynurenate)IBA 09/2003
1	KynurenineIBA 09/2003
1	Transaminases (Aminotransferases)IBA 09/2003
1	Finasteride (Propecia)FDA LinkGeneric 07/2003
1	Pregnanolone (Allopregnanolone)IBA 07/2003

Therapy/Procedure

2	Acupuncture Therapy 11/2015 - 01/2013
1	Brain-Computer Interfaces 01/2017
1	Therapeutics 07/2016
1	Deep Brain Stimulation 12/2010
1	Ovariectomy (Oophorectomy) 05/2007